BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 7, 2021
View Archived Issues
Erasca opens enrollment in phase Ib/II study of ERAS-007 in advanced or metastatic solid tumors
Read More
Interim data from RUBY study presented for OKG-0301 in AC
Read More
Intraocular pressure lowering by soluble guanylate cyclase inhibitor ID-65-CW69 studied in monkeys
Read More
Positive 12- and 24-month data reported from ongoing XLRP phase I/II study
Read More
Medshine Discovery divulges new CDK inhibitors
Read More
Aucentra Therapeutics patents CDK inhibitors
Read More
DarwinHealth and Bristol Myers Squibb establish Novel Cancer Target Initiative
Read More
IMPACT Therapeutics identifies new Wee1 inhibitors
Read More
CB-5083 ameliorates disease pathology in VCP-mutated knock-in mouse model of IBMPFD
Read More
Betta Pharmaceuticals synthesizes EGFR inhibitors
Read More
Phase II trial shows improved PFS when relacorilant is added to nab-paclitaxel in ovarian cancer
Read More
Beijing Dongfang Biotech patents IL-10-containing fusion proteins for cancer
Read More
Interim phase II data on miricorilant in NASH show liver fat reductions
Read More
ABP-201 for treating angiogenic eye diseases
Read More
Discovery and preclinical characterization of novel bifunctional anti-PD-1 x IL-15 proteins
Read More
Aslan Pharmaceuticals presents phase I data for the IL13RA1 inhibitor ASLAN-004
Read More
Enanta reports data from ongoing phase Ib study of EDP-514 for chronic HBV
Read More
Landos initiates phase II study of omilancor in Crohn's disease
Read More
Topline phase IIa data reported on FOL-005 for alopecia
Read More
China's NMPA gives clinical trial approval for JS-201 for advanced malignancies
Read More
China NMPA grants conditional approval to pamiparib for advanced ovarian cancer
Read More
Pivotal trial of arimoclomol in ALS does not meet primary and secondary endpoints
Read More
Gut microbiome affects protein folding in brain, muscles
Read More
PLEK2 as prognostic biomarker and therapeutic target in ESCC
Read More
FDA clears IND for Lyndra's LYN-014 for weekly treatment of opioid use disorder
Read More
Pivotal study evaluates PD-G-506-A for margin assessment during breast conserving surgery
Read More
